SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Ovintiv Inc. (OVV.TO) trades at a trailing P/E of 15.8, forward P/E of 10.3. Trailing earnings yield is 6.33%, forward earnings yield 9.69%. PEG 1.17.
Criteria proven by this page:
- VALUE (85/100, Pass) — P/E is below market average (15.8); earnings yield beats bond yields (6.33%).
- Forward P/E 10.3 (down from trailing 15.8) — analysts expect earnings to grow, which would improve the valuation.
- PEG Ratio 1.17 — between 1.0–2.0 indicates moderate valuation relative to growth.
- Trailing Earnings Yield 6.33% — exceeds typical bond yields (~4.3%), making equity attractive vs fixed income. Forward yield improves to 9.69% as earnings recover.
Overall SharesGrow Score: 58/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
85/100
Price-to-Earnings & upside
Proven by this page
✗
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — OVV.TO
Valuation Multiples
P/E (TTM)15.8
Forward P/E10.3
PEG Ratio1.17
Forward PEG0.19
P/B Ratio0.00
P/S Ratio2.24
EV/EBITDA0.0
Per Share Data
EPS (TTM)$4.78
Forward EPS (Est.)$7.31
Book Value / Share$0.00
Revenue / Share$33.64
FCF / Share$0.00
Yields & Fair Value
Earnings Yield6.33%
Forward Earnings Yield9.69%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$-5.35 |
$2.92B |
$-944M |
-32.4% |
| 2017 |
$4.25 |
$4.44B |
$827M |
18.6% |
| 2018 |
$5.57 |
$5.94B |
$1.07B |
18% |
| 2019 |
$0.90 |
$6.73B |
$234M |
3.5% |
| 2020 |
$-23.47 |
$6.09B |
$-6.1B |
-100.2% |
| 2021 |
$5.32 |
$8.66B |
$1.42B |
16.4% |
| 2022 |
$14.08 |
$12.46B |
$3.64B |
29.2% |
| 2023 |
$7.90 |
$10.66B |
$2.09B |
19.6% |
| 2024 |
$4.21 |
$9.15B |
$1.13B |
12.3% |
| 2025 |
$4.78 |
$8.74B |
$1.24B |
14.2% |
